Targeting MIF attenuates bleomycin-induced pulmonary fibrosis by inhibiting succinate accumulation
Year: 2026
Type: article
Abstract: Background Pulmonary fibrosis is a devastating disease with limited therapeutic options. Macrophage migration inhibitory factor (MIF) has been implicated in fibrogenesis, but its metabolic regulatory mechanisms remain unclear. Methods We established a bleomycin (BLM)-induced pulmonary fibrosis mouse model and TGF-β1-stimulated primary lung fibroblasts. MIF was inhibited in vivo using a MIF-targeting shRNA lentivirus (shMIF) or the pharmacological inhibitor (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1), and in vitro using ISO-1. Fibrotic progression, aerobic glycolysis, PHD expression, HIF-1α protein levels, and succinate accumulation were assessed. Results MIF inhibition reduced aerobic glycolytic flux, as evidenced by decreased ECAR and lactate levels. Mechanistically, MIF downregulated PHD1/2 expression, increased HIF-1α protein levels, and promoted succinate accumulation under normoxic conditions, accompanied by enhanced fibrogenic responses. Conclusion These findings suggest that MIF promotes pulmonary fibrosis in association with the PISD-succinate-HIF-1α axis, potentially involving reduced PHD expression and increased HIF-1α protein levels. Rescue experiments further suggest that MIF promotes fibroblast activation at least in part through glycolysis-dependent mechanisms.
Source: Frontiers in Physiology
Authors: Hai Bing Lan(Data curation, Formal analysis, Funding acquisition, Investigation, Writing – original draft, Writing – review & editing), Hui Wang(Data curation, Validation, Writing – review & editing), Lin Lin Deng(Project administration, Resources, Supervision, Writing – review & editing), Li Xia Xie(Data curation, Formal analysis, Methodology, Resources, Validation, Writing – review & editing), Jian Ning Xu(Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Resources, Visualization, Writing – original draft, Writing – review & editing)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7235041185
